Copyright
©The Author(s) 2017.
World J Cardiol. Jan 26, 2017; 9(1): 39-46
Published online Jan 26, 2017. doi: 10.4330/wjc.v9.i1.39
Published online Jan 26, 2017. doi: 10.4330/wjc.v9.i1.39
Before MitraClip | After MitraClip | P value | |
NYHA class III and IV, n (%) | 43 (98) | 16 (35) | < 0.001 |
Mitral regurgitation (severe) | 44 (100) | 6 (14) | < 0.001 |
Left atrial diameter (mm) | 50 ± 6 | 49 ± 7 | 0.039 |
Left atrial volume (mL) | 114 ± 43 | 102 ± 42 | 0.008 |
LV end-diastolic diameter (mm) | 55 ± 10 | 54 ± 11 | 0.308 |
LV end-systolic diameter (mm) | 42 ± 12 | 41 ± 12 | 0.367 |
LV end-diastolic volume (mL) | 158 ± 69 | 159 ± 75 | 0.866 |
LV end-systolic volume (mL) | 95 ± 63 | 95 ± 61 | 0.993 |
LV ejection fraction (%) | 42 ± 15 | 44 ± 13 | 0.216 |
Severe tricuspid regurgitation, n (%) | 12 (27) | 9 (20) | 0.763 |
sPAP (mmHg) | 44 ± 13 | 27 ± 10 | 0.027 |
- Citation: Gotzmann M, Sprenger I, Ewers A, Mügge A, Bösche L. One-year outcome of percutaneous mitral valve repair in patients with severe symptomatic mitral valve regurgitation. World J Cardiol 2017; 9(1): 39-46
- URL: https://www.wjgnet.com/1949-8462/full/v9/i1/39.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i1.39